LIVE

CTEV

Claritev Corporation

CTEV

NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $552.3M

$32.64

▲ +0.74%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$11.50 - $74.07

P/E

-1.88

Fwd P/E

-2.05

Beta

0.77

Div Yield

0.00%

Avg Vol

143.4K

Shares Out

17.0M

Mkt Cap

$552.3M

Price action

Price chart

Down 23.8% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

5 reasons

  • Proprietary data analytics algorithms detecting claims overcharges and cost inefficiencies
  • Extensive contracted provider network with negotiated discounts across the U.S.
  • Integrated platform combining payment integrity, network management, and predictive analytics
  • 44+ years of healthcare industry expertise and established relationships with major payers
  • Advanced data science capabilities for benefit plan optimization and clinical outcome improvement
▼

Bear Case

1 risk

  • Low volatility (beta 0.8).

Growth

Stable outlook

Rising healthcare costs driving demand for cost management and claims accuracy solutions

Value

Deep value opportunity - significant discount to Healthcare IT & Services peers

Momentum

Hot

+85.6% over 3m

Quality

Excellent

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 6, 2026

“
Q2 26 RECAP

MAY 7, 2026

Reported EPS of -$4.41 vs -$3.81 consensus (-15.8% surprise). Revenue of $244.7M vs $236.4M expected (+3.5%).

EPS miss
Rev beat +3.5%

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-15.8%

Next: May 6, 2026

Revenue trend · last 8Q

—

—

-5%

-1%

+3%

+7%

+6%

+6%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$233.5M

$230.5M

$232.1M

$231.3M

$241.6M

$246.0M

$246.6M

$244.7M

Margins · last 8Q

Gross

—

Operating

—

Profit

-30.1%

View full earnings history →

Wall Street consensus

3 analysts · 67% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

67%

Hold

1

33%

Sell

0%

Median Price Target

$28.00

▼ -14.2% vs $32.64

Low $28.00
Median $28.00
High $28.00

Latest: Barclays · $28.00 · Apr 24, 2026

1 analyst covering

View full analyst page →

vs Industry

How CTEV stacks vs Medical - Healthcare Information Services

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.